Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by Mortimeron Jan 13, 2022 1:23pm
224 Views
Post# 34313528

Wait for it…

Wait for it…In the letter to shareholders in December GA mentioned the company hit the low end of their sale projections in 2021 however the last release didn't reflect that. This means that all the sales were made during the last quarter after the latest earnings release but before the letter to shareholders. This also means the current sp does not reflect those sales yet, so now is the time to hold or buy more shares (after all why would you sell knowing the sales made to date haven't even been reported yet) Something else to consider; THE COMPANY HIT THE SALES TARGET even though sales for 2021 didnt really even start until after September, so think of how prosperous this current quarter will be, and the one after this, and the one after that! It's been a fun ride, and today the company is poised for a great return on our investments. 
<< Previous
Bullboard Posts
Next >>